Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-03-29
1994-12-20
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514302, 546114, 546115, 548154, C07D491048, C07D49504, A61K 31435
Patent
active
053746350
ABSTRACT:
Compounds having the formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomemlar nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection and in preventing the formation of atherosclerotic plaques.
REFERENCES:
patent: 4629733 (1986-12-01), Muller et al.
patent: 5034403 (1991-07-01), Effland et al.
patent: 5095031 (1992-03-01), Brooks et al.
patent: 5190968 (1993-03-01), Gillard et al.
Sheinkman et al. Chem Ab., vol. 67, 54017 (1967).
Biniecki et al. Chem Ab., vol. 98, 197936 (1983).
Pakula et al., Chem Ab., vol. 105, 190835 (1986).
Hutchinson John H.
Leger Serge
Dentz Bernard
Merck Frosst Canada Inc.
Rose David L.
Yang Mollie M.
LandOfFree
Furo[3,2-b]pyridines and thieno[3,2-b]pyridines as inhibitors of does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Furo[3,2-b]pyridines and thieno[3,2-b]pyridines as inhibitors of, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Furo[3,2-b]pyridines and thieno[3,2-b]pyridines as inhibitors of will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2386351